+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In-Vitro Diagnostics Quality Control Market Research Report by Distributor, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4904896
  • Report
  • July 2021
  • Region: Global
  • 197 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global In-Vitro Diagnostics Quality Control Market will Grow to USD 1,648.75 Million by 2026, at a CAGR of 7.04%

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Helena Laboratories
  • Randox Laboratories Ltd
  • Roche Diagnostics
  • Sero as
The Global In-Vitro Diagnostics Quality Control Market size was estimated at USD 1,095.99 Million in 2020 and expected to reach USD 1,169.47 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.04% to reach USD 1,648.75 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the In-Vitro Diagnostics Quality Control to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Distributor, the In-Vitro Diagnostics Quality Control Market was studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls.
  • Based on Offering, the In-Vitro Diagnostics Quality Control Market was studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Urine-Based Controls, Whole-Blood-Based Controls, and Whole-Blood-Based Controls.
  • Based on Application, the In-Vitro Diagnostics Quality Control Market was studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics.
  • Based on End User, the In-Vitro Diagnostics Quality Control Market was studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes.
  • Based on Region, the In-Vitro Diagnostics Quality Control Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the In-Vitro Diagnostics Quality Control Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In-Vitro Diagnostics Quality Control Market, including Abbott Laboratories Inc., Bio-Rad Laboratories, Inc., Helena Laboratories, Ortho Clinical Diagnostics, Inc., Randox Laboratories Ltd, Roche Diagnostics, Seracare Life Sciences, Inc., Sero as, Technopath Clinical Diagnostics, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global In-Vitro Diagnostics Quality Control Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Quality Control Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Quality Control Market?
4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Quality Control Market?
5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Quality Control Market?
6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Quality Control Market?
7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Quality Control Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Helena Laboratories
  • Randox Laboratories Ltd
  • Roche Diagnostics
  • Sero as
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Distributor Outlook
3.4. Offering Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Geriatric population and prevalence of chronic and infectious diseases
5.1.1.2. Rise in the number of accredited clinical laboratories and adoption of third-party quality controls
5.1.1.3. Demand for advanced diagnostics for sensitive reports and accurate diagnosis
5.1.2. Restraints
5.1.2.1. High cost of IVD quality control services
5.1.2.2. Unfavorable reimbursement
5.1.3. Opportunities
5.1.3.1. Rise in the demand for multi-analyte controls
5.1.3.2. Growth opportunities in emerging countries
5.1.4. Challenges
5.1.4.1. Limited regulations for clinical laboratory accreditation in several emerging countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. In-Vitro Diagnostics Quality Control Market, by Distributor
6.1. Introduction
6.2. OEM
6.3. Third-Party Control Manufacturers
6.3.1. Independent Manufacturer Controls
6.3.2. Instrument-Specific Controls

7. In-Vitro Diagnostics Quality Control Market, by Offering
7.1. Introduction
7.2. Data Management Solutions
7.3. Quality Assurance Services
7.4. Quality Control Products
7.4.1. Urine-Based Controls
7.4.2. Whole-Blood-Based Controls
7.4.3. Whole-Blood-Based Controls

8. In-Vitro Diagnostics Quality Control Market, by Application
8.1. Introduction
8.2. Clinical Chemistry
8.3. Coagulation or Hemostasis
8.4. Hematology
8.5. Immunochemistry
8.6. Microbiology
8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End User
9.1. Introduction
9.2. Clinical Laboratories
9.3. Hospitals
9.4. Research & Academic Institutes

10. Americas In-Vitro Diagnostics Quality Control Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific In-Vitro Diagnostics Quality Control Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand

12. Europe, Middle East & Africa In-Vitro Diagnostics Quality Control Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories Inc.
14.2. Bio-Rad Laboratories, Inc.
14.3. Helena Laboratories
14.4. Ortho Clinical Diagnostics, Inc.
14.5. Randox Laboratories Ltd
14.6. Roche Diagnostics
14.7. Seracare Life Sciences, Inc.
14.8. Sero as
14.9. Technopath Clinical Diagnostics
14.10. Thermo Fisher Scientific Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 (USD MILLION)
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 (USD MILLION)
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (%)
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2026
FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (%)
FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2020 VS 2026 (USD MILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2026
FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, 2018-2026 (USD MILLION)
FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 28. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2026 (USD MILLION)
FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, 2018-2026 (USD MILLION)
FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 37. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2026
FIGURE 39. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2026 (USD MILLION)
FIGURE 40. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 41. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, 2018-2026 (USD MILLION)
FIGURE 42. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 43. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2018-2026 (USD MILLION)
FIGURE 48. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 49. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD MILLION)
FIGURE 50. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 51. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 52. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 53. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2026
FIGURE 54. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 55. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 56. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 57. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 58. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 59. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 60. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 86. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 87. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 88. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 89. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: FPNV POSITIONING MATRIX
FIGURE 90. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 91. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2026 (USD MILLION)
TABLE 27. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SCORES
TABLE 57. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: BUSINESS STRATEGY
TABLE 58. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: PRODUCT SATISFACTION
TABLE 59. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: RANKING
TABLE 60. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 61. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: MERGER & ACQUISITION
TABLE 62. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 63. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 64. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: INVESTMENT & FUNDING
TABLE 65. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 66. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories Inc.
  • Bio-Rad Laboratories, Inc.
  • Helena Laboratories
  • Ortho Clinical Diagnostics, Inc.
  • Randox Laboratories Ltd
  • Roche Diagnostics
  • Seracare Life Sciences, Inc.
  • Sero as
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll